首页 > 最新文献

Journal of preventive medicine and hygiene最新文献

英文 中文
Tetanus: historical and palaeopathological aspects considering its current health impact. 破伤风:历史和古病理学方面考虑到其目前的健康影响。
Pub Date : 2025-01-31 eCollection Date: 2024-12-01 DOI: 10.15167/2421-4248/jpmh2024.65.4.3376
Francesco Maria Galassi, Raffaella Bianucci, Simon T Donell, Valentina Vittori, Andreas Nerlich, Mariano Martini, Elena Varotto

The present article summarises the historical and palaeopathological evidence of tetanus, an ineradicable yet vaccine-preventable infectious disease caused by Clostridium tetani. The antiquity of the disease is described thanks to historical written sources, artistic references and very recent palaeogenetic data. A recollection of now long-supplanted therapies is offered together with a focus on the introduction of an effective vaccine. Moreover, a potential identification of tetanus in the Bible is analysed and general considerations on the current health relevance of tetanus are presented.

本文总结了破伤风的历史和古病理学证据,破伤风是由破伤风梭菌引起的一种不可根除但疫苗可预防的传染病。由于历史文献、艺术参考文献和最近的古成因数据,这种疾病的古老性得以描述。在回顾已被长期取代的治疗方法的同时,重点介绍了有效疫苗的引进。此外,还分析了《圣经》中对破伤风的潜在识别,并提出了对破伤风目前与健康有关的一般考虑。
{"title":"Tetanus: historical and palaeopathological aspects considering its current health impact.","authors":"Francesco Maria Galassi, Raffaella Bianucci, Simon T Donell, Valentina Vittori, Andreas Nerlich, Mariano Martini, Elena Varotto","doi":"10.15167/2421-4248/jpmh2024.65.4.3376","DOIUrl":"10.15167/2421-4248/jpmh2024.65.4.3376","url":null,"abstract":"<p><p>The present article summarises the historical and palaeopathological evidence of tetanus, an ineradicable yet vaccine-preventable infectious disease caused by Clostridium tetani. The antiquity of the disease is described thanks to historical written sources, artistic references and very recent palaeogenetic data. A recollection of now long-supplanted therapies is offered together with a focus on the introduction of an effective vaccine. Moreover, a potential identification of tetanus in the Bible is analysed and general considerations on the current health relevance of tetanus are presented.</p>","PeriodicalId":94106,"journal":{"name":"Journal of preventive medicine and hygiene","volume":"65 4","pages":"E580-E585"},"PeriodicalIF":0.0,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11870127/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143545335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evolution of SARS-CoV-2 epidemics in pediatric population in Liguria (North-west Italy) from March 2020 to December 2022: what could we have learned? 2020年3月至2022年12月利古里亚(意大利西北部)儿科人群中SARS-CoV-2流行的演变:我们可以从中学到什么?
Pub Date : 2025-01-31 eCollection Date: 2024-12-01 DOI: 10.15167/2421-4248/jpmh2024.65.4.3348
Marcello Mariani, Francesca Bagnasco, Camilla Sticchi, Raffaele Spiazzi, Irene Giberti, Giancarlo Icardi, Elio Castagnola

Introduction: This retrospective analysis aims to follow the course of SARS-CoV-2 infections in pediatric population residing in Liguria, North-west Italy, from March 2020 to December 2022 and to relate it to the regional and national containment measures adopted, to assess the representativeness of the infection rate observed at the national level and to analyze the vaccination rates in different pediatric groups.

Methods: First episodes of SARS-CoV-2 infections registered in the national surveillance system were extracted and further anonymously analyzed for subjects aging ≤ 19 years. The absolute number of cases diagnosed daily during each year was compared to the number of residents in the region and graphical representations were used to visualize the trends in infection rates both annually and weekly in each year. Through narrative analysis, the relationship between changes in IR and key social events was analyzed.Applying the direct standardization method, the epidemiology of SARS-CoV-2 infection in pediatric population was compared with that observed in the same age group in Italy.All analyses were performed using Stata and Microsoft Excel.

Results: In the study period, 106,537 (17.4%) cases of SARS-CoV-2 infection were registered in subjects ≤ 19 years, out of a total of 610,404 cases reported in Liguria during that period. In the summer of 2020 the IR was close to zero, while later we observed increases and decreases in the IR in relation to activities and social restrictions adopted. Direct standardization showed an almost perfect coincidence between the expected cases in Italy, based on the Liguria incidence, and the observed cases.

Conclusions: Our results show that, in absence of effective therapies and vaccines, strict non-medical interventions (e.g. use of masks, improving indoor ventilation, physical social distancing, general lockdown) can be the only actions to counter the spread of a respiratory infection.

本回顾性分析旨在跟踪2020年3月至2022年12月居住在意大利西北部利古里亚的儿童人群中SARS-CoV-2的感染过程,并将其与所采取的区域和国家控制措施联系起来,评估在国家层面观察到的感染率的代表性,并分析不同儿童群体的疫苗接种率。方法:抽取国家监测系统中登记的首次SARS-CoV-2感染病例,对年龄≤19岁的受试者进行匿名分析。将每年每天诊断的病例的绝对数量与该地区的居民数量进行比较,并使用图形表示来可视化每年和每周感染率的趋势。通过叙事分析,分析IR变化与重大社会事件的关系。采用直接标准化方法,比较意大利儿童与同年龄组人群的SARS-CoV-2感染流行病学。所有分析均使用Stata和Microsoft Excel进行。结果:在研究期间,在利古里亚报告的610,404例病例中,≤19岁的受试者中登记了106,537例(17.4%)SARS-CoV-2感染病例。在2020年夏天,IR接近于零,而后来我们观察到与所采取的活动和社会限制相关的IR增加和减少。直接标准化表明,根据利古里亚的发病率,意大利的预期病例与观察到的病例几乎完全吻合。结论:我们的研究结果表明,在缺乏有效疗法和疫苗的情况下,严格的非医疗干预措施(例如使用口罩、改善室内通风、保持身体社交距离、全面封锁)可能是对抗呼吸道感染传播的唯一行动。
{"title":"Evolution of SARS-CoV-2 epidemics in pediatric population in Liguria (North-west Italy) from March 2020 to December 2022: what could we have learned?","authors":"Marcello Mariani, Francesca Bagnasco, Camilla Sticchi, Raffaele Spiazzi, Irene Giberti, Giancarlo Icardi, Elio Castagnola","doi":"10.15167/2421-4248/jpmh2024.65.4.3348","DOIUrl":"10.15167/2421-4248/jpmh2024.65.4.3348","url":null,"abstract":"<p><strong>Introduction: </strong>This retrospective analysis aims to follow the course of SARS-CoV-2 infections in pediatric population residing in Liguria, North-west Italy, from March 2020 to December 2022 and to relate it to the regional and national containment measures adopted, to assess the representativeness of the infection rate observed at the national level and to analyze the vaccination rates in different pediatric groups.</p><p><strong>Methods: </strong>First episodes of SARS-CoV-2 infections registered in the national surveillance system were extracted and further anonymously analyzed for subjects aging ≤ 19 years. The absolute number of cases diagnosed daily during each year was compared to the number of residents in the region and graphical representations were used to visualize the trends in infection rates both annually and weekly in each year. Through narrative analysis, the relationship between changes in IR and key social events was analyzed.Applying the direct standardization method, the epidemiology of SARS-CoV-2 infection in pediatric population was compared with that observed in the same age group in Italy.All analyses were performed using Stata and Microsoft Excel.</p><p><strong>Results: </strong>In the study period, 106,537 (17.4%) cases of SARS-CoV-2 infection were registered in subjects ≤ 19 years, out of a total of 610,404 cases reported in Liguria during that period. In the summer of 2020 the IR was close to zero, while later we observed increases and decreases in the IR in relation to activities and social restrictions adopted. Direct standardization showed an almost perfect coincidence between the expected cases in Italy, based on the Liguria incidence, and the observed cases.</p><p><strong>Conclusions: </strong>Our results show that, in absence of effective therapies and vaccines, strict non-medical interventions (e.g. use of masks, improving indoor ventilation, physical social distancing, general lockdown) can be the only actions to counter the spread of a respiratory infection.</p>","PeriodicalId":94106,"journal":{"name":"Journal of preventive medicine and hygiene","volume":"65 4","pages":"E483-E490"},"PeriodicalIF":0.0,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11870141/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143545251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccine Acceptance among travelers directed to areas with risk of dengue: a pilot study. 前往登革热危险地区的旅行者接受疫苗:一项试点研究。
Pub Date : 2025-01-31 eCollection Date: 2024-12-01 DOI: 10.15167/2421-4248/jpmh2024.65.4.3414
Gianmarco Troiano, Isuri Dinupa Madumali Warnakulasuriya Fernando, Alessandra Nardi

Introduction: Dengue is a vector-borne viral disease that causes a million of cases every year (including deaths). A tetravalent live-attenuated virus vaccine is available for this infection. The aim of our work was to study vaccine acceptance, attitudes and behaviors among travelers heading to areas with risk of dengue.

Methods: We conducted a cross-sectional study in February-April 2024 at the Travel Medicine Clinic of Rozzano (Italy), focusing on travelers directed to areas with risk of dengue. We collected the following information anonymously: travel destination, reason for travel, date/month of departure, length of stay, and accepted/refused vaccinations.

Results: 58 travelers were included in our study and they chose 23 countries for their travel with a mean length of stay of 16.98 days. Five (8.62%) refused dengue vaccination because they considered the vaccination not necessary (80%), or for its cost (20%). There was no statistically significant difference between men and women in vaccination acceptance. Age and length of stay did not influence the percentage of refusals.

Conclusions: Although the results are limited by the small number of travelers, they highlighted the problem of vaccine hesitancy among travelers, and further efforts are needed to address this phenomenon.

登革热是一种媒介传播的病毒性疾病,每年导致100万病例(包括死亡)。针对这种感染有一种四价减毒活疫苗。我们工作的目的是研究前往登革热危险地区的旅行者对疫苗的接受程度、态度和行为。方法:我们于2024年2月至4月在Rozzano(意大利)旅行医学诊所进行了一项横断面研究,重点关注前往登革热风险地区的旅行者。我们匿名收集了以下信息:旅行目的地、旅行原因、出发日期/月份、停留时间、接受/拒绝接种疫苗。结果:58名游客参与了我们的研究,他们选择了23个国家进行旅行,平均停留时间为16.98天。5人(8.62%)拒绝接种登革热疫苗,因为他们认为接种疫苗没有必要(80%)或因为疫苗费用(20%)。在接受疫苗接种方面,男女之间没有统计学上的显著差异。年龄和住院时间对拒签率没有影响。结论:虽然结果受限于旅行者人数较少,但它们突出了旅行者中疫苗犹豫的问题,需要进一步努力解决这一现象。
{"title":"Vaccine Acceptance among travelers directed to areas with risk of dengue: a pilot study.","authors":"Gianmarco Troiano, Isuri Dinupa Madumali Warnakulasuriya Fernando, Alessandra Nardi","doi":"10.15167/2421-4248/jpmh2024.65.4.3414","DOIUrl":"10.15167/2421-4248/jpmh2024.65.4.3414","url":null,"abstract":"<p><strong>Introduction: </strong>Dengue is a vector-borne viral disease that causes a million of cases every year (including deaths). A tetravalent live-attenuated virus vaccine is available for this infection. The aim of our work was to study vaccine acceptance, attitudes and behaviors among travelers heading to areas with risk of dengue.</p><p><strong>Methods: </strong>We conducted a cross-sectional study in February-April 2024 at the Travel Medicine Clinic of Rozzano (Italy), focusing on travelers directed to areas with risk of dengue. We collected the following information anonymously: travel destination, reason for travel, date/month of departure, length of stay, and accepted/refused vaccinations.</p><p><strong>Results: </strong>58 travelers were included in our study and they chose 23 countries for their travel with a mean length of stay of 16.98 days. Five (8.62%) refused dengue vaccination because they considered the vaccination not necessary (80%), or for its cost (20%). There was no statistically significant difference between men and women in vaccination acceptance. Age and length of stay did not influence the percentage of refusals.</p><p><strong>Conclusions: </strong>Although the results are limited by the small number of travelers, they highlighted the problem of vaccine hesitancy among travelers, and further efforts are needed to address this phenomenon.</p>","PeriodicalId":94106,"journal":{"name":"Journal of preventive medicine and hygiene","volume":"65 4","pages":"E478-E482"},"PeriodicalIF":0.0,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11870135/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143545460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the effect of Sacubitril/Valsartan with Losartan and Captopril in improving right ventricular function in patients with right heart failure, a randomized clinical controlled trial. 沙比利/缬沙坦与氯沙坦、卡托普利改善右心衰患者右心室功能的随机临床对照试验比较
Pub Date : 2024-10-31 eCollection Date: 2024-09-01 DOI: 10.15167/2421-4248/jpmh2024.65.3.3305
Marjan Hajahmadi, Elahe Zeinali, Pegah Joghataie, Mahboubeh Pazoki

Background: There is evidence supporting the efficacy of Sacubitril /Valsartan for improving left heart failure, but few studies have examined its effects on right ventricular (RV) dysfunction. The current study aimed to investigate the effects of Sacubitril /Valsartan on RV dysfunction in patients with right heart failure.

Methods: The current study was a randomized and parallel clinical trial study. Patients over 18 years with any degree of right heart failure regardless of Left ventricular ejection fraction (LVEF) were included. The included patients were assigned randomly to three study arms using simple random allocation, i.e. the intervention group (Sacubitril Valsartan recipients) and the control groups (Losartan and Captopril recipients). The SPSS software version 19 was used for data analysis.

Results: The changes in LVEF, RV FAC, RV diameter, DOE grade, and TAPSE in the Sacubitril/Valsartan group were significantly higher than the other two groups. The severity of RV dysfunction, as well as TR (Tricuspid Regurgitation) severity, decreased significantly three months after the intervention compared to the beginning of the intervention in all groups especially in the Sacubitril/Valsartan group (p: 0.006). The mortality rate in the Sacubitril/Valsartan, Losartan, and Captopril groups, were 2 (6.7%), 2 (11.2%), and 1 (7.7%) respectively (p: 0.83). Also, 27.6, 62.5, and 7.7% of cases in the Sacubitril/Valsartan, Losartan, and Captopril reached to optimum dose (p: 0.006).

Conclusions: Considering the results, it seems that Sacubitril/Valsartan has a positive effect on improving RV dysfunction in patients with right heart disorders.

背景:有证据支持Sacubitril /缬沙坦改善左心衰的疗效,但很少有研究考察其对右心室功能障碍的影响。本研究旨在探讨Sacubitril /缬沙坦对右心衰患者右室功能障碍的影响。方法:本研究为随机平行临床试验研究。无论左心室射血分数(LVEF)如何,18岁以上任何程度的右心衰患者均被纳入研究。纳入的患者采用简单随机分配的方法随机分为三个研究组,即干预组(Sacubitril缬沙坦接受者)和对照组(氯沙坦和卡托普利接受者)。采用SPSS 19版软件进行数据分析。结果:沙奎比利/缬沙坦组LVEF、RV FAC、RV直径、DOE分级、TAPSE的变化均显著高于其他两组。干预3个月后,所有组的右室功能障碍严重程度以及三尖瓣反流严重程度均较干预开始时显著降低,尤其是苏比里尔/缬沙坦组(p: 0.006)。沙比利/缬沙坦组、氯沙坦组和卡托普利组的死亡率分别为2(6.7%)、2(11.2%)和1 (7.7%)(p: 0.83)。此外,27.6%、62.5%和7.7%的Sacubitril/缬沙坦、氯沙坦和卡托普利达到最佳剂量(p: 0.006)。结论:综合以上结果,Sacubitril/缬沙坦对改善右心疾患右室功能障碍具有积极作用。
{"title":"Comparison of the effect of Sacubitril/Valsartan with Losartan and Captopril in improving right ventricular function in patients with right heart failure, a randomized clinical controlled trial.","authors":"Marjan Hajahmadi, Elahe Zeinali, Pegah Joghataie, Mahboubeh Pazoki","doi":"10.15167/2421-4248/jpmh2024.65.3.3305","DOIUrl":"https://doi.org/10.15167/2421-4248/jpmh2024.65.3.3305","url":null,"abstract":"<p><strong>Background: </strong>There is evidence supporting the efficacy of Sacubitril /Valsartan for improving left heart failure, but few studies have examined its effects on right ventricular (RV) dysfunction. The current study aimed to investigate the effects of Sacubitril /Valsartan on RV dysfunction in patients with right heart failure.</p><p><strong>Methods: </strong>The current study was a randomized and parallel clinical trial study. Patients over 18 years with any degree of right heart failure regardless of Left ventricular ejection fraction (LVEF) were included. The included patients were assigned randomly to three study arms using simple random allocation, i.e. the intervention group (Sacubitril Valsartan recipients) and the control groups (Losartan and Captopril recipients). The SPSS software version 19 was used for data analysis.</p><p><strong>Results: </strong>The changes in LVEF, RV FAC, RV diameter, DOE grade, and TAPSE in the Sacubitril/Valsartan group were significantly higher than the other two groups. The severity of RV dysfunction, as well as TR (Tricuspid Regurgitation) severity, decreased significantly three months after the intervention compared to the beginning of the intervention in all groups especially in the Sacubitril/Valsartan group (p: 0.006). The mortality rate in the Sacubitril/Valsartan, Losartan, and Captopril groups, were 2 (6.7%), 2 (11.2%), and 1 (7.7%) respectively (p: 0.83). Also, 27.6, 62.5, and 7.7% of cases in the Sacubitril/Valsartan, Losartan, and Captopril reached to optimum dose (p: 0.006).</p><p><strong>Conclusions: </strong>Considering the results, it seems that Sacubitril/Valsartan has a positive effect on improving RV dysfunction in patients with right heart disorders.</p>","PeriodicalId":94106,"journal":{"name":"Journal of preventive medicine and hygiene","volume":"65 3","pages":"E395-E402"},"PeriodicalIF":0.0,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11698105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142934115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A historico-medical perspective on ancient epidemics and their impact on past human societies. 古代流行病的历史医学观点及其对过去人类社会的影响。
Pub Date : 2024-10-31 eCollection Date: 2024-09-01 DOI: 10.15167/2421-4248/jpmh2024.65.3.3383
Francesco M Galassi, Elena Varotto, Elena Percivaldi, Valentina Vittori, Luigi Ingaliso, Mauro Vaccarezza, Mariano Martini, Domenico Ribatti

The present article reviews the major historical plague epidemics that characterised human history by combining data derived from historical sources and biomedical evidence emerged in recent years thanks to advancements of palaeogenetics and palaeopathology. Notes are offered on the Plague of Athens, the Antonine Plague, the Plague of Cyprian, the Justinian Plague, the Black Death down to more recent centuries and presenting key aspects that continued to be preserved over time and would also partly characterise the recent COVID-19 pandemic.

本文结合来自历史资料的数据和近年来由于古遗传学和古病理学的进步而出现的生物医学证据,回顾了人类历史上主要的鼠疫流行。介绍了近几个世纪以来的雅典瘟疫、安东尼瘟疫、塞浦路斯瘟疫、查士丁尼瘟疫、黑死病,并介绍了随着时间的推移而继续保存下来的关键方面,这些方面也将在一定程度上描述最近的COVID-19大流行。
{"title":"A historico-medical perspective on ancient epidemics and their impact on past human societies.","authors":"Francesco M Galassi, Elena Varotto, Elena Percivaldi, Valentina Vittori, Luigi Ingaliso, Mauro Vaccarezza, Mariano Martini, Domenico Ribatti","doi":"10.15167/2421-4248/jpmh2024.65.3.3383","DOIUrl":"https://doi.org/10.15167/2421-4248/jpmh2024.65.3.3383","url":null,"abstract":"<p><p>The present article reviews the major historical plague epidemics that characterised human history by combining data derived from historical sources and biomedical evidence emerged in recent years thanks to advancements of palaeogenetics and palaeopathology. Notes are offered on the Plague of Athens, the Antonine Plague, the Plague of Cyprian, the Justinian Plague, the Black Death down to more recent centuries and presenting key aspects that continued to be preserved over time and would also partly characterise the recent COVID-19 pandemic.</p>","PeriodicalId":94106,"journal":{"name":"Journal of preventive medicine and hygiene","volume":"65 3","pages":"E456-E463"},"PeriodicalIF":0.0,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11698106/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142933879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aerobic or Resistance Exercise for maximum Cardiovascular Disease Protection? An Appraisal of the Current Level of Evidence. 有氧运动或阻力运动最大程度地保护心血管疾病?对当前证据水平的评估。
Pub Date : 2024-10-31 eCollection Date: 2024-09-01 DOI: 10.15167/2421-4248/jpmh2024.65.3.3198
Nikos Dimitriadis, Demosthenes Panagiotakos

Introduction: The beneficial role of physical activity on the cardiovascular system has been well established and appreciated. The aim of this narrative review was to present a summary of the latest recommendations for physical activity, and to evaluate the most recent scientific evidence regarding the role of aerobic and or resistance exercise in relation to atherosclerotic cardiovascular disease (ASCVD) risk.

Methods: Narrative review; searches were performed in PubMed, Scopus and Google Scholar. The guidelines of major Organizations (i.e., European Society of Cardiology, American College of Cardiology/ American Heart Association, American College of Sports Medicine, and World Heart Federation, World Heart Organization) were also retrieved and presented here.

Results: Engagement in regular aerobic exercise is strongly recommended for all people and by all scientific organizations for reducing ASCVD mortality and morbidity. Resistance exercise should be implemented in addition to aerobic, however, its individual effects on ASCVD risk are not well established.

Conclusions: A reduction of sedentary behavior at population level reduces the healthcare costs by multiple ways. Effective approaches should be implemented that include behavior theory-based interventions, e.g., goal-setting, re-evaluation of goals, self-monitoring, and feedback. Most important is to encourage activity that individuals enjoy and/or can be included in their daily life.

体育活动对心血管系统的有益作用已经得到了很好的证实和认可。这篇叙述性综述的目的是总结最新的体育活动建议,并评估关于有氧运动和/或阻力运动在动脉粥样硬化性心血管疾病(ASCVD)风险中的作用的最新科学证据。方法:叙事回顾;在PubMed, Scopus和b谷歌Scholar中进行搜索。主要组织(即欧洲心脏病学会、美国心脏病学会/美国心脏协会、美国运动医学院、世界心脏联合会、世界心脏组织)的指南也被检索并在这里展示。结果:所有科学组织都强烈建议所有人进行有规律的有氧运动,以降低ASCVD的死亡率和发病率。除了有氧运动外,还应进行阻力运动,然而,其对ASCVD风险的个体影响尚未得到很好的确定。结论:在人群水平上减少久坐行为可通过多种方式降低医疗保健费用。应该实施有效的方法,包括基于行为理论的干预措施,如目标设定、目标重新评估、自我监控和反馈。最重要的是鼓励个人喜欢和/或可以包括在他们的日常生活中的活动。
{"title":"Aerobic or Resistance Exercise for maximum Cardiovascular Disease Protection? An Appraisal of the Current Level of Evidence.","authors":"Nikos Dimitriadis, Demosthenes Panagiotakos","doi":"10.15167/2421-4248/jpmh2024.65.3.3198","DOIUrl":"https://doi.org/10.15167/2421-4248/jpmh2024.65.3.3198","url":null,"abstract":"<p><strong>Introduction: </strong>The beneficial role of physical activity on the cardiovascular system has been well established and appreciated. The aim of this narrative review was to present a summary of the latest recommendations for physical activity, and to evaluate the most recent scientific evidence regarding the role of aerobic and or resistance exercise in relation to atherosclerotic cardiovascular disease (ASCVD) risk.</p><p><strong>Methods: </strong>Narrative review; searches were performed in PubMed, Scopus and Google Scholar. The guidelines of major Organizations (i.e., European Society of Cardiology, American College of Cardiology/ American Heart Association, American College of Sports Medicine, and World Heart Federation, World Heart Organization) were also retrieved and presented here.</p><p><strong>Results: </strong>Engagement in regular aerobic exercise is strongly recommended for all people and by all scientific organizations for reducing ASCVD mortality and morbidity. Resistance exercise should be implemented in addition to aerobic, however, its individual effects on ASCVD risk are not well established.</p><p><strong>Conclusions: </strong>A reduction of sedentary behavior at population level reduces the healthcare costs by multiple ways. Effective approaches should be implemented that include behavior theory-based interventions, e.g., goal-setting, re-evaluation of goals, self-monitoring, and feedback. Most important is to encourage activity that individuals enjoy and/or can be included in their daily life.</p>","PeriodicalId":94106,"journal":{"name":"Journal of preventive medicine and hygiene","volume":"65 3","pages":"E323-E329"},"PeriodicalIF":0.0,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11698100/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142933912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
War and Health: the devastating impact of conflict on Wellbeing and Humanitarian Crises. 战争与健康:冲突对福祉和人道主义危机的破坏性影响。
Pub Date : 2024-10-31 eCollection Date: 2024-09-01 DOI: 10.15167/2421-4248/jpmh2024.65.3.3412
Mariano Martini, Lucia Valchi, Elvira Massaro, Roberto Parrella, Davide Orsini

Health is a precious asset, essential for both individuals and communities. The wars that have affected various parts of the world in recent years have had a detrimental impact on health, leading to malnutrition and an increased vulnerability to epidemic diseases among the population, especially the poorest. Hospitals and healthcare facilities themselves have become primary strategic targets in many war zones. The destruction of infrastructure and hospitals, along with challenges in obtaining clean water and access to medicines, has contributed to the resurgence of epidemic diseases in countries where they had been eradicated. Additionally, the difficulty in ensuring vaccination programs for children raises the risk of these diseases spreading to areas typically free from them. The authors reflect on the consequences of wars on the health of populations and the close link between health and peace, presenting the latest data on ongoing epidemics in countries affected by war.

健康是一项宝贵资产,对个人和社区都至关重要。近年来影响世界各地的战争对健康产生了有害影响,导致人口,特别是最贫穷人口营养不良和更容易感染流行病。医院和保健设施本身已成为许多战区的主要战略目标。基础设施和医院遭到破坏,再加上在获得清洁水和获得药品方面面临挑战,导致流行病在已被消灭的国家死灰复燃。此外,确保儿童接种疫苗计划的困难增加了这些疾病传播到通常没有这些疾病的地区的风险。提交人思考了战争对人口健康的后果以及健康与和平之间的密切联系,提出了受战争影响国家中正在发生的流行病的最新数据。
{"title":"War and Health: the devastating impact of conflict on Wellbeing and Humanitarian Crises.","authors":"Mariano Martini, Lucia Valchi, Elvira Massaro, Roberto Parrella, Davide Orsini","doi":"10.15167/2421-4248/jpmh2024.65.3.3412","DOIUrl":"https://doi.org/10.15167/2421-4248/jpmh2024.65.3.3412","url":null,"abstract":"<p><p>Health is a precious asset, essential for both individuals and communities. The wars that have affected various parts of the world in recent years have had a detrimental impact on health, leading to malnutrition and an increased vulnerability to epidemic diseases among the population, especially the poorest. Hospitals and healthcare facilities themselves have become primary strategic targets in many war zones. The destruction of infrastructure and hospitals, along with challenges in obtaining clean water and access to medicines, has contributed to the resurgence of epidemic diseases in countries where they had been eradicated. Additionally, the difficulty in ensuring vaccination programs for children raises the risk of these diseases spreading to areas typically free from them. The authors reflect on the consequences of wars on the health of populations and the close link between health and peace, presenting the latest data on ongoing epidemics in countries affected by war.</p>","PeriodicalId":94106,"journal":{"name":"Journal of preventive medicine and hygiene","volume":"65 3","pages":"E464-E468"},"PeriodicalIF":0.0,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11698113/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142934203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eosinophil count and clinical outcome in patients with acute exacerbation of Chronic obstructive pulmonary disease. 慢性阻塞性肺疾病急性加重期患者嗜酸性粒细胞计数与临床转归
Pub Date : 2024-10-31 eCollection Date: 2024-09-01 DOI: 10.15167/2421-4248/jpmh2024.65.3.3267
Neda Faraji, Idraak Hussain Bhat, Majid Akrami, Hadiseh Hosamirudsari, Hossein Kazemizadeh, Aryan Naderi, Fariba Mansouri

Introduction: We examined the association of blood eosinophil counts at the time of AECOPD hospitalization with the risk of ICU admission as well as the hospital lengths of stay and mortality.

Methods: In the current retrospective study, the association between blood eosinophil counts in COPD patients at the time of AECOPD hospitalization and the risk of subsequent ICU admission as well as mortality was assessed. The chi-squared test and t-test were used to compare categorical and continuous variables. The statistical significance level was set at 0.05. Kaplan-Meier curves for mortality as well as ICU admission up to 40 days after discharge from the index hospitalization were constructed using the determined optimal eosinophil threshold derived above and for the predetermined ≥ 300 vs < 300 cells/μL threshold. All analyses were performed using SPSS version 19.

Results: Antibiotic prescription was significantly associated with increased ICU admission (OR = 1.57; confidence interval [95% CI] = 1.02-2.42. Patients with higher FEV1 had decreased ICU admission (OR = 0.98, 95% CI = 0.97-1.01, p = 0.1) as well as all-cause mortality compared (OR = 0.98, 95% CI= 0.92-1.04, p = 0.58). There were significantly greater mortality rates for patients with higher ESR (OR = 1.02, CI =1.01-1.03, p = 0.01) and CRP (OR = 1.02, 95% CI = 1.01-1.03, p = 0.01). There were significantly lower ICU admission rates for patients with higher FVC (OR = 0.97, 95% CI = 0.95-0.98, p = 0.002).

Conclusions: Blood eosinophil count could help determine the risk of ICU admission as well as mortality in COPD patients at the time of hospitalization.

前言:我们研究了AECOPD住院时血嗜酸性粒细胞计数与ICU入院风险、住院时间和死亡率的关系。方法:在本回顾性研究中,评估AECOPD住院时COPD患者血嗜酸性粒细胞计数与随后ICU入院风险及死亡率的关系。分类变量与连续变量的比较采用卡方检验和t检验。统计学显著性水平设为0.05。采用上述确定的最佳嗜酸性粒细胞阈值和预先确定的≥300 vs < 300细胞/μL阈值,构建死亡率和出院后40天ICU入院Kaplan-Meier曲线。所有分析均使用SPSS version 19进行。结果:抗生素处方与ICU入院率增加显著相关(OR = 1.57;置信区间[95% CI] = 1.02-2.42。FEV1较高的患者ICU住院率降低(OR = 0.98, 95% CI= 0.97-1.01, p = 0.1),全因死亡率降低(OR = 0.98, 95% CI= 0.92-1.04, p = 0.58)。ESR越高(OR = 1.02, CI =1.01-1.03, p = 0.01)、CRP越高(OR = 1.02, 95% CI =1.01-1.03, p = 0.01),患者死亡率越高。FVC高的患者ICU住院率明显降低(OR = 0.97, 95% CI = 0.95 ~ 0.98, p = 0.002)。结论:血液嗜酸性粒细胞计数可以帮助确定COPD患者住院时的ICU入院风险和死亡率。
{"title":"Eosinophil count and clinical outcome in patients with acute exacerbation of Chronic obstructive pulmonary disease.","authors":"Neda Faraji, Idraak Hussain Bhat, Majid Akrami, Hadiseh Hosamirudsari, Hossein Kazemizadeh, Aryan Naderi, Fariba Mansouri","doi":"10.15167/2421-4248/jpmh2024.65.3.3267","DOIUrl":"https://doi.org/10.15167/2421-4248/jpmh2024.65.3.3267","url":null,"abstract":"<p><strong>Introduction: </strong>We examined the association of blood eosinophil counts at the time of AECOPD hospitalization with the risk of ICU admission as well as the hospital lengths of stay and mortality.</p><p><strong>Methods: </strong>In the current retrospective study, the association between blood eosinophil counts in COPD patients at the time of AECOPD hospitalization and the risk of subsequent ICU admission as well as mortality was assessed. The chi-squared test and t-test were used to compare categorical and continuous variables. The statistical significance level was set at 0.05. Kaplan-Meier curves for mortality as well as ICU admission up to 40 days after discharge from the index hospitalization were constructed using the determined optimal eosinophil threshold derived above and for the predetermined ≥ 300 vs < 300 cells/μL threshold. All analyses were performed using SPSS version 19.</p><p><strong>Results: </strong>Antibiotic prescription was significantly associated with increased ICU admission (OR = 1.57; confidence interval [95% CI] = 1.02-2.42. Patients with higher FEV1 had decreased ICU admission (OR = 0.98, 95% CI = 0.97-1.01, p = 0.1) as well as all-cause mortality compared (OR = 0.98, 95% CI= 0.92-1.04, p = 0.58). There were significantly greater mortality rates for patients with higher ESR (OR = 1.02, CI =1.01-1.03, p = 0.01) and CRP (OR = 1.02, 95% CI = 1.01-1.03, p = 0.01). There were significantly lower ICU admission rates for patients with higher FVC (OR = 0.97, 95% CI = 0.95-0.98, p = 0.002).</p><p><strong>Conclusions: </strong>Blood eosinophil count could help determine the risk of ICU admission as well as mortality in COPD patients at the time of hospitalization.</p>","PeriodicalId":94106,"journal":{"name":"Journal of preventive medicine and hygiene","volume":"65 3","pages":"E389-E394"},"PeriodicalIF":0.0,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11698108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142934159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing equity in the distribution of hospital beds in Lorestan, western Iran: a regional analysis. 评估伊朗西部Lorestan医院病床分配的公平性:区域分析。
Pub Date : 2024-10-31 eCollection Date: 2024-09-01 DOI: 10.15167/2421-4248/jpmh2024.65.3.3356
Meysam Behzadifar, Farzaneh Shaygan, Parvin Ebrahimi, Saeed Shahabi, Samad Azari, Banafshe Darvishi Teli, Mariano Martini, Masoud Behzadifar

Background: Equity in health service delivery ensures that resources are distributed based on need, minimizing barriers to access and reducing health disparities. Hospital beds are a critical healthcare resource, essential for providing timely and effective medical care. This study aims to evaluate the equity in the distribution of hospital beds in Lorestan Province, western Iran, using the Gini coefficient and Lorenz curve as analytical tools.

Methods: Data on the number of hospital beds and population statistics for each city in Lorestan were collected from the Lorestan University of Medical Sciences and the Statistical Center of Iran. The equity of hospital bed distribution was assessed using the Gini coefficient and Lorenz curve, with analyses conducted using R statistical software.

Results: Lorestan Province, with a population of 1,678,873, has significant disparities in hospital bed distribution. The Gini coefficient for hospital beds was 0.27, indicating moderate inequality. The Lorenz curve showed a substantial deviation from the equity line, highlighting the imbalance. Khorramabad and Aligudarz exhibited the highest inequality, while Rumeshkan, Kuhdasht, and Poldokhtar had more equitable distributions.

Conclusions: The study reveals notable inequities in hospital bed distribution in Lorestan Province, emphasizing the need for targeted policy interventions. Strategic resource allocation, infrastructure development, and policy reforms are essential to enhance healthcare equity. Continuous monitoring and consideration of additional healthcare resources and socioeconomic factors are recommended for comprehensive future assessments.

背景:卫生服务提供的公平性确保资源按需分配,最大限度地减少获取障碍,缩小卫生差距。医院病床是一种重要的医疗资源,对于提供及时有效的医疗服务至关重要。本研究旨在评估医院床位分配的公平性在洛雷斯坦省,伊朗西部,使用基尼系数和洛伦兹曲线作为分析工具。方法:收集洛雷斯坦医科大学和伊朗统计中心提供的洛雷斯坦各市医院床位数和人口统计数据。采用基尼系数和Lorenz曲线对医院床位分配公平性进行评价,并采用R统计软件进行分析。结果:洛勒斯坦省人口1,678,873人,床位分布差异显著。医院床位的基尼系数为0.27,表明不平等程度中等。洛伦兹曲线与权益线有很大的偏离,突出了不平衡。霍拉马巴德和阿里古达尔兹表现出最严重的不平等,而鲁米什坎、库达什特和波多赫塔尔的分配更为公平。结论:该研究揭示了洛雷斯坦省医院床位分配的显著不平等,强调了有针对性的政策干预的必要性。战略性资源配置、基础设施发展和政策改革对于增强医疗公平至关重要。建议持续监测和考虑额外的医疗资源和社会经济因素,以便进行全面的未来评估。
{"title":"Assessing equity in the distribution of hospital beds in Lorestan, western Iran: a regional analysis.","authors":"Meysam Behzadifar, Farzaneh Shaygan, Parvin Ebrahimi, Saeed Shahabi, Samad Azari, Banafshe Darvishi Teli, Mariano Martini, Masoud Behzadifar","doi":"10.15167/2421-4248/jpmh2024.65.3.3356","DOIUrl":"https://doi.org/10.15167/2421-4248/jpmh2024.65.3.3356","url":null,"abstract":"<p><strong>Background: </strong>Equity in health service delivery ensures that resources are distributed based on need, minimizing barriers to access and reducing health disparities. Hospital beds are a critical healthcare resource, essential for providing timely and effective medical care. This study aims to evaluate the equity in the distribution of hospital beds in Lorestan Province, western Iran, using the Gini coefficient and Lorenz curve as analytical tools.</p><p><strong>Methods: </strong>Data on the number of hospital beds and population statistics for each city in Lorestan were collected from the Lorestan University of Medical Sciences and the Statistical Center of Iran. The equity of hospital bed distribution was assessed using the Gini coefficient and Lorenz curve, with analyses conducted using R statistical software.</p><p><strong>Results: </strong>Lorestan Province, with a population of 1,678,873, has significant disparities in hospital bed distribution. The Gini coefficient for hospital beds was 0.27, indicating moderate inequality. The Lorenz curve showed a substantial deviation from the equity line, highlighting the imbalance. Khorramabad and Aligudarz exhibited the highest inequality, while Rumeshkan, Kuhdasht, and Poldokhtar had more equitable distributions.</p><p><strong>Conclusions: </strong>The study reveals notable inequities in hospital bed distribution in Lorestan Province, emphasizing the need for targeted policy interventions. Strategic resource allocation, infrastructure development, and policy reforms are essential to enhance healthcare equity. Continuous monitoring and consideration of additional healthcare resources and socioeconomic factors are recommended for comprehensive future assessments.</p>","PeriodicalId":94106,"journal":{"name":"Journal of preventive medicine and hygiene","volume":"65 3","pages":"E449-E455"},"PeriodicalIF":0.0,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11698115/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142934101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers and challenges of establishing family physician policy for urban population; evidence from a qualitative study in Iran. 城市人口家庭医生政策制定的障碍与挑战证据来自伊朗的一项定性研究。
Pub Date : 2024-10-31 eCollection Date: 2024-09-01 DOI: 10.15167/2421-4248/jpmh2024.65.3.3346
Roghayeh Mohammadibakhsh, Rahim Sohrabi, Negar Aghighi, Samira Alihosseini, Masoud Behzadifar, Mariano Martini, Aidin Aryankhesal

Background: Family physicians play a crucial role in healthcare delivery systems worldwide. In Iran, the family physician program has been introduced in only two provinces, with its expansion to other regions currently stalled due to various challenges. This study aims to identify the barriers and challenges hindering the effective implementation of the family physician program in urban areas of Iran.

Methods: This qualitative study utilized purposeful sampling to select health system policymakers, senior administrators, and physicians as participants. Data were collected through semi-structured interviews with 32 participants until saturation was reached. The data were analyzed using grounded theory, involving open, axial, and selective coding to identify key themes and sub-themes.

Results: The primary challenge in implementing the urban family physician program was conflicting interests among stakeholders, identified as the core category. Key contributing factors included payment mechanism complexities, stewardship, structural issues, financial constraints, and cultural elements. Specialist physicians, in particular, resisted the program's implementation, often employing reverse referral as a coping strategy. These challenges collectively hindered the nationwide rollout of the program.

Conclusions: Addressing the barriers to implementing urban family physician policies requires a comprehensive reassessment of stakeholder roles and a restructuring of the payment system. Additionally, proactive efforts to resolve the complex contextual challenges within the healthcare system are essential for the successful implementation of these policies.

背景:家庭医生在全球医疗保健系统中发挥着至关重要的作用。在伊朗,家庭医生计划只在两个省推行,由于各种挑战,目前向其他地区的扩张停滞不前。本研究旨在确定阻碍伊朗城市地区有效实施家庭医生计划的障碍和挑战。方法:本定性研究采用有目的的抽样方法,选择卫生系统决策者、高级管理人员和医生作为参与者。通过与32名参与者的半结构化访谈收集数据,直到达到饱和。使用基础理论对数据进行分析,包括开放、轴向和选择性编码,以确定关键主题和子主题。结果:实施城市家庭医生计划的主要挑战是利益相关者之间的利益冲突,这是核心类别。主要的影响因素包括支付机制的复杂性、管理、结构问题、财政限制和文化因素。专科医生尤其反对该计划的实施,经常采用反向转诊作为应对策略。这些挑战共同阻碍了该计划在全国范围内的推广。结论:解决实施城市家庭医生政策的障碍需要对利益相关者的角色进行全面的重新评估,并对支付系统进行重组。此外,积极主动地解决医疗保健系统内复杂的环境挑战对于成功实施这些政策至关重要。
{"title":"Barriers and challenges of establishing family physician policy for urban population; evidence from a qualitative study in Iran.","authors":"Roghayeh Mohammadibakhsh, Rahim Sohrabi, Negar Aghighi, Samira Alihosseini, Masoud Behzadifar, Mariano Martini, Aidin Aryankhesal","doi":"10.15167/2421-4248/jpmh2024.65.3.3346","DOIUrl":"https://doi.org/10.15167/2421-4248/jpmh2024.65.3.3346","url":null,"abstract":"<p><strong>Background: </strong>Family physicians play a crucial role in healthcare delivery systems worldwide. In Iran, the family physician program has been introduced in only two provinces, with its expansion to other regions currently stalled due to various challenges. This study aims to identify the barriers and challenges hindering the effective implementation of the family physician program in urban areas of Iran.</p><p><strong>Methods: </strong>This qualitative study utilized purposeful sampling to select health system policymakers, senior administrators, and physicians as participants. Data were collected through semi-structured interviews with 32 participants until saturation was reached. The data were analyzed using grounded theory, involving open, axial, and selective coding to identify key themes and sub-themes.</p><p><strong>Results: </strong>The primary challenge in implementing the urban family physician program was conflicting interests among stakeholders, identified as the core category. Key contributing factors included payment mechanism complexities, stewardship, structural issues, financial constraints, and cultural elements. Specialist physicians, in particular, resisted the program's implementation, often employing reverse referral as a coping strategy. These challenges collectively hindered the nationwide rollout of the program.</p><p><strong>Conclusions: </strong>Addressing the barriers to implementing urban family physician policies requires a comprehensive reassessment of stakeholder roles and a restructuring of the payment system. Additionally, proactive efforts to resolve the complex contextual challenges within the healthcare system are essential for the successful implementation of these policies.</p>","PeriodicalId":94106,"journal":{"name":"Journal of preventive medicine and hygiene","volume":"65 3","pages":"E434-E441"},"PeriodicalIF":0.0,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11698112/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142934077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of preventive medicine and hygiene
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1